AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Nov 27, 2013
30016_dirs_2013-11-27_722607b3-e7a3-440f-bf12-4fc69030a0ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-11-25
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-25 | Common Stock | M | 13000 | $25.45 | Acquired | 378389 | Direct |
| 2013-11-25 | Common Stock | M | 7000 | $41.935 | Acquired | 385389 | Direct |
| 2013-11-25 | Common Stock | M | 25000 | $50.00 | Acquired | 410389 | Direct |
| 2013-11-25 | Common Stock | S | 20079 | $105.4584 | Disposed | 390310 | Direct |
| 2013-11-25 | Common Stock | S | 19010 | $106.1424 | Disposed | 371300 | Direct |
| 2013-11-26 | Common Stock | M | 13000 | $25.45 | Acquired | 384300 | Direct |
| 2013-11-26 | Common Stock | M | 7000 | $41.935 | Acquired | 391300 | Direct |
| 2013-11-26 | Common Stock | M | 25000 | $50.00 | Acquired | 416300 | Direct |
| 2013-11-26 | Common Stock | S | 38789 | $104.7924 | Disposed | 377511 | Direct |
| 2013-11-26 | Common Stock | S | 300 | $105.61 | Disposed | 377211 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-25 | Non-Qualified Stock Option (right to buy) | $25.45 | M | 13000 | Disposed | 2014-02-04 | Common Stock (13000) | Direct |
| 2013-11-25 | Non-Qualified Stock Option (right to buy) | $41.935 | M | 7000 | Disposed | 2014-02-13 | Common Stock (7000) | Direct |
| 2013-11-25 | Non-Qualified Stock Option (right to buy) | $50.00 | M | 25000 | Disposed | 2014-02-13 | Common Stock (25000) | Direct |
| 2013-11-26 | Non-Qualified Stock Option (right to buy) | $25.45 | M | 13000 | Disposed | 2014-02-04 | Common Stock (13000) | Direct |
| 2013-11-26 | Non-Qualified Stock Options (right to buy) | $41.935 | M | 7000 | Disposed | 2014-02-13 | Common Stock (7000) | Direct |
| 2013-11-26 | Non-Qualified Stock Options (right to buy) | $50.00 | M | 25000 | Disposed | 2014-02-13 | Common Stock (25000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49000 | Indirect |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2013.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $104.91 to $105.90, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4.
F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $105.91 to $106.43, inclusive.
F4: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $104.48 to $105.445, inclusive.
F5: Grant of options to buy shares of common stock becomes exercisable as to 22,000 shares on 02/05/2005, 02/05/2006, 02/05/2007 and 02/05/2008, and the remaining 18,072 shares on 02/05/2009.
F6: Grant of options to buy shares of common stock becomes exercisable as to 12,000 shares on 02/14/2008, 02/14/2009, 02/14/2010 and 02/14/2011, and the remaining 9,616 shares on 02/14/2012.
F7: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date 02/14/2008 of the date of grant.